Investors & Media International Stem Cell Corporation Announces Positive Interim Data From Primate Study Parkinson's Disease Cell Therapy International Stem Cell Corporation to Present at 26th Annual ROTH Conference International Stem Cell Corporation Completes Pre-IND Meeting With FDA for Parkinson's Disease Cell Therapy International Stem Cell Corporation's Co-Chairman and CEO Andrey Semechkin PhD Publishes Letter to Shareholders 2014 Letter to Shareholders International Stem Cell Corporation to Present at Biotech Showcase 2014 International Stem Cell Corporation's Liver Program Receives Award International Stem Cell Corporation Announces $10.25 Million Purchase Agreement With Lincoln Park Capital Fund, LLC International Stem Cell Corporation Announces Major Advance in Stem Cell Technology International Stem Cell Corporation Announces 41% Increase in Revenues for Third Quarter 2013 8 9 10 11 12 13 14 15 16 17 18 << < > >>
